Showing results (111-120 of 226) with videos related to
Sort By:
Pageof 23
Age and Ageing|May 29, 2023
Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med studyChristopher Etherton-Beer, Amy Page, Vasi Naganathan, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 11, 2021
Nortriptyline for pain in knee osteoarthritis: a double-blind randomised controlled trial in New Zealand general practiceBen Hudson, Jonathan A Williman, Lisa K Stamp, et al.Health and Quality of Life Outcomes|May 30, 2026
Proxy reports on the EQ-5D-5L in residential aged care facilities: a validation studyTiet-Hanh Dao-Tran, Syed Afroz Keramat, Christopher Etherton-Beer, et al.Bipolar Disorders|November 26, 2003
Mood-stabilizers: the archeology of the conceptMargaret Harris, Summit Chandran, Nabonita Chakraborty, et al.The International Journal of Risk & Safety in Medicine|June 7, 2014
Ninety-three cases of alcohol dependence following SSRI treatmentLouise Brookwell, Carys Hogan, David Healy, et al.Nature|January 7, 2006
Three-dimensional brittle shear fracturing by tensile crack interactionDavid Healy, Richard R Jones, Robert E HoldsworthBioelectricity|September 2, 2021
Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Major Malformations: The Importance of Serotonin for Embryonic Development and the Effect of Serotonin Inhibition on the Occurrence of MalformationsAnick Bérard, Michael Levin, Thomas Sadler, et al.History of Psychiatry|February 3, 2006
The impact of mood stabilizers on bipolar disorder: the 1890s and 1990s comparedMargaret Harris, Summit Chandran, Nabonita Chakraborty, et al.Internal and Emergency Medicine|April 2, 2015
Has evidence-based medicine left quackery behind?Florian Naudet, Bruno Falissard, Rémy Boussageon, et al.British Journal of Sports Medicine|July 9, 2024
Prevalence of therapeutic use exemptions at the Olympic Games and Paralympic Games: an analysis of data from 2016 to 2022Alan Vernec, David Healy, Tamar Banon, et al.Pageof 23